Clinical Trial

Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial

Name: Moses 2.0 vs Magneto for HoLEP - a Randomized Controlled Trial — clinical trial record (NCT07632742)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The objective of this study is to compare the Magneto 150 holmium laser to the current MOSES 2.0 technology to see if there is a benefit in decreased hemostasis time intraoperatively.

Trial Details

NCT Number	NCT07632742
Lead Sponsor	Northwestern University Collaborators: Cook Group Incorporated
Conditions	Enlarged Prostate (BPH), Benign Prostatic Hyperplasia
Enrollment	180 participants
Start Date	2026-06
Primary Completion	2027-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-06-08